Next 10 |
A look at the top 10 most actives in the United States Akanda Corp. (AKAN) rose 52.9% to $0.1422 on volume of 108,274,564 shares CytomX Therapeutics Inc. (CTMX) rose 71.8% to $2.8 on volume of 31,588,176 shares Getaround Inc. (GETR) rose 35.9% to $0.2754 on volume of 26,693,135 shares P...
2024-05-01 06:00:03 ET Luke Sergott from Barclays issued a price target of $36.00 for TXG on 2024-05-01 05:08:00. The adjusted price target was set to $36.00. At the time of the announcement, TXG was trading at $29.28. The overall price target consensus is at $47.50 with...
2024-04-30 23:32:01 ET 10x Genomics, Inc. (TXG) Q1 2024 Earnings Conference Call April 30, 2024 16:30 ET Company Participants Cassie Corneau - Director of Investor Relations & Strategic Finance Serge Saxonov - Chief Executive Officer & Co-Founder Justin M...
2024-04-30 17:01:17 ET Gainers: Powell Industries ( POWL ) +19% . Root ( ROOT ) +16% . TransMedics Group ( TMDX ) +11% . Inari Medical ( NARI ) +7% . MannKind Corporation ( MNKD ) +5% . Losers: CVRx ( CVRX ) -16% ...
2024-04-30 16:53:43 ET More on 10x Genomics 10x Genomics, Inc. (TXG) Q4 2023 Earnings Call Transcript 10x Genomics Q1 2024 Earnings Preview 10x Genomics begins shipping Chromium GEM-X products Seeking Alpha’s Quant Rating on 10x Genomics Histor...
10x Genomics Reports First Quarter 2024 Financial Results PR Newswire PLEASANTON, Calif. , April 30, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter end...
2024-04-29 17:20:31 ET More on 10x Genomics 10x Genomics, Inc. (TXG) Q4 2023 Earnings Call Transcript 10x Genomics begins shipping Chromium GEM-X products 10x Genomics GAAP EPS of -$0.41 misses by $0.05, revenue of $184M beats by $0.26M Seeking Alpha’s...
2024-04-25 04:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-19 03:54:17 ET Summary ARK Invest's 13F portfolio value decreased by 15% this quarter, with the number of holdings increasing from 223 to 230. The top three holdings in the portfolio are Coinbase Global, Tesla, and Block, making up around 20% of the assets. ARK Invest ...
A look at the top 10 most actives in the United States SiNtx Technologies Inc. (SINT) rose 73.2% to $0.0646 on volume of 191,555,690 shares AGBA Group Holding Limited (AGBA) rose 245.0% to $1.38 on volume of 41,065,125 shares TIAN RUIXIANG Holdings Ltd (TIRX) rose 135.2% to $1.14 on volum...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
-0.68% Change Percent:
10x Genomics Inc. Company Name:
TXG Stock Symbol:
NYSE Market:
A look at the top 10 most actives in the United States Akanda Corp. (AKAN) rose 52.9% to $0.1422 on volume of 108,274,564 shares CytomX Therapeutics Inc. (CTMX) rose 71.8% to $2.8 on volume of 31,588,176 shares Getaround Inc. (GETR) rose 35.9% to $0.2754 on volume of 26,693,135 shares P...
2024-05-01 06:00:03 ET Luke Sergott from Barclays issued a price target of $36.00 for TXG on 2024-05-01 05:08:00. The adjusted price target was set to $36.00. At the time of the announcement, TXG was trading at $29.28. The overall price target consensus is at $47.50 with...
10x Genomics Reports First Quarter 2024 Financial Results PR Newswire PLEASANTON, Calif. , April 30, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first quarter end...